EMEA-002684-PIP02-21
Key facts
| Invented name |
Pyrukynd
|
| Active substance |
Mitapivat
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0150/2022
|
| PIP number |
EMEA-002684-PIP02-21
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of thalassaemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Agios Netherlands B.V.
Email: medinfo@agios.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|